IS1945B - (1S,2S)-1-(4-hýdroxýfenýl)-2-(4-hýdroxý-4-fenýlpíperidín-1-ýl)-1-própanól metansúlfónat tríhýdrat - Google Patents

(1S,2S)-1-(4-hýdroxýfenýl)-2-(4-hýdroxý-4-fenýlpíperidín-1-ýl)-1-própanól metansúlfónat tríhýdrat

Info

Publication number: IS1945B
Authority: IS; Iceland
Prior art keywords: phenylpiperidin; hydroxyphenyl; hydroxy; propanol methanesulfonate; methanesulfonate trihydrate
Prior art date: 1995-08-11

Application number

IS4643A

Other languages

English (en)

Other versions

IS4643A (is

Inventor

Maria Andino Marta

Gene Sinay Terry

Fred Fiese Eugene

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-11

Filing date

1997-12-30

Publication date

2004-08-13

1997-12-30 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1997-12-30 Publication of IS4643A publication Critical patent/IS4643A/is

2004-08-13 Publication of IS1945B publication Critical patent/IS1945B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Virology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

IS4643A 1995-08-11 1997-12-30 (1S,2S)-1-(4-hýdroxýfenýl)-2-(4-hýdroxý-4-fenýlpíperidín-1-ýl)-1-própanól metansúlfónat tríhýdrat IS1945B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US223895P	1995-08-11	1995-08-11
PCT/IB1996/000592 WO1997007098A1 (en)	1995-08-11	1996-06-20	(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate

Publications (2)

Publication Number	Publication Date
IS4643A IS4643A (is)	1997-12-30
IS1945B true IS1945B (is)	2004-08-13

Family

ID=21699847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4643A IS1945B (is)	1995-08-11	1997-12-30	(1S,2S)-1-(4-hýdroxýfenýl)-2-(4-hýdroxý-4-fenýlpíperidín-1-ýl)-1-própanól metansúlfónat tríhýdrat

Country Status (41)

Country	Link
US (1)	US6008233A (is)
EP (1)	EP0843661B1 (is)
JP (1)	JP3099072B2 (is)
KR (1)	KR100291882B1 (is)
CN (2)	CN1615861A (is)
AP (1)	AP755A (is)
AR (1)	AR004676A1 (is)
AT (1)	ATE215072T1 (is)
AU (1)	AU710984B2 (is)
BG (1)	BG63678B1 (is)
BR (1)	BR9610766A (is)
CA (1)	CA2228752C (is)
CO (1)	CO4750830A1 (is)
CZ (1)	CZ296236B6 (is)
DE (1)	DE69620191T2 (is)
DK (1)	DK0843661T3 (is)
DZ (1)	DZ2083A1 (is)
ES (1)	ES2170857T3 (is)
GT (1)	GT199600051A (is)
HR (1)	HRP960372B1 (is)
HU (1)	HUP9802862A3 (is)
IL (1)	IL122649A (is)
IS (1)	IS1945B (is)
MA (1)	MA23957A1 (is)
NO (1)	NO310458B1 (is)
NZ (1)	NZ309134A (is)
OA (1)	OA10664A (is)
PE (1)	PE4898A1 (is)
PL (1)	PL185603B1 (is)
PT (1)	PT843661E (is)
RO (1)	RO120134B1 (is)
RS (1)	RS49521B (is)
RU (1)	RU2140910C1 (is)
SA (1)	SA96170171B1 (is)
SK (1)	SK284209B6 (is)
TN (1)	TNSN96104A1 (is)
TR (1)	TR199800208T1 (is)
TW (1)	TW495502B (is)
UA (1)	UA59341C2 (is)
WO (1)	WO1997007098A1 (is)
ZA (1)	ZA966760B (is)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6046213A (en) *	1994-08-18	2000-04-04	Pfizer Inc.	Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives
EP0843661B1 (en) *	1995-08-11	2002-03-27	Pfizer Inc.	(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
GB9820405D0 (en)	1998-09-18	1998-11-11	Smithkline Beecham Plc	Process
AU3676100A (en) *	1999-04-09	2000-11-14	Mochida Pharmaceutical Co., Ltd.	Remedies for neuropathic pain
GB9920917D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel process
GB9920919D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel compound
US6620830B2 (en) *	2000-04-21	2003-09-16	Pfizer, Inc.	Thyroid receptor ligands
YU27801A (sh)	2000-04-28	2003-04-30	Pfizer Products Inc.	Postupak za dobijanje trihidrata mezilatne soli 1-(4- hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)-1-propanola i korisnih intermedijera
YU27701A (sh) *	2000-04-28	2003-04-30	Pfizer Products Inc.	Postupak za dobijanje trihidrata mezilatne soli 1-(4- hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)1-propanola
IL154378A0 (en)	2000-08-16	2003-09-17	Upjohn Co	Compounds for the treatment of addictive disorders
EP1186303A3 (en) *	2000-09-06	2003-12-10	Pfizer Products Inc.	Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist
EP1674087A1 (en)	2000-10-02	2006-06-28	Pfizer Products Inc.	Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
IL145584A0 (en)	2000-10-02	2002-06-30	Pfizer Prod Inc	Nmda nr2b antagonists for treatment
UA73619C2 (en) *	2000-12-13	2005-08-15	Pfizer Prod Inc	Stable pharmaceutical compositions of nmda receptor agonist (variants) and method of treatment
JP4398247B2 (ja) *	2001-10-19	2010-01-13	富山化学工業株式会社	アルキルエーテル誘導体またはその塩
KR100517638B1 (ko)	2002-04-08	2005-09-28	주식회사 엘지생명과학	게미플록사신 산염의 새로운 제조방법
KR101052122B1 (ko)	2005-10-25	2011-07-26	시오노기세야쿠 가부시키가이샤	아미노디히드로티아진 유도체
EP2147914B1 (en)	2007-04-24	2014-06-04	Shionogi&Co., Ltd.	Aminodihydrothiazine derivatives substituted with cyclic groups
EP2151435A4 (en)	2007-04-24	2011-09-14	Shionogi & Co	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MX2010013256A (es)	2008-06-13	2010-12-21	Shionogi & Co	Derivado heterociclico que contiene azufre que tiene actividad inhibitoria de beta-secretasa.
JPWO2010047372A1 (ja)	2008-10-22	2012-03-22	塩野義製薬株式会社	Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体
JPWO2011071135A1 (ja)	2009-12-11	2013-04-22	塩野義製薬株式会社	オキサジン誘導体
CA2816285A1 (en)	2010-10-29	2012-05-03	Shionogi & Co., Ltd.	Naphthyridine derivative
EP2634188A4 (en)	2010-10-29	2014-05-07	Shionogi & Co	FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
TW201247635A (en)	2011-04-26	2012-12-01	Shionogi & Co	Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them
JP2016501827A (ja)	2012-10-24	2016-01-21	塩野義製薬株式会社	Ｂａｃｅ１阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
EP3194403B1 (en)	2014-09-15	2019-02-06	Rugen Holdings (Cayman) Limited	Pyrrolopyrimidine derivatives as nr2b nmda receptor antagonists
WO2016049048A1 (en) *	2014-09-22	2016-03-31	Rugen Holdings (Cayman) Limited	Treatment of anxiety disorders and autism spectrum disorders
US10221182B2 (en)	2015-02-04	2019-03-05	Rugen Holdings (Cayman) Limited	3,3-difluoro-piperidine derivatives as NR2B NMDA receptor antagonists
US10584127B2 (en)	2015-06-01	2020-03-10	Rugen Holdings (Cayman) Limited	3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists
US11000526B2 (en)	2016-11-22	2021-05-11	Rugen Holdings (Cayman) Limited	Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990014087A1 (en) *	1989-05-17	1990-11-29	Pfizer Inc.	2-piperidino-1-alkanol derivatives as antiischemic agents
US5272160A (en) *	1989-05-17	1993-12-21	Pfizer Inc	2-piperidino-1-alkanol derivatives as antiischemic agents
US6046213A (en) *	1994-08-18	2000-04-04	Pfizer Inc.	Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives
EP0843661B1 (en) *	1995-08-11	2002-03-27	Pfizer Inc.	(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate

1996
- 1996-06-20 EP EP96916266A patent/EP0843661B1/en not_active Expired - Lifetime
- 1996-06-20 UA UA98020673A patent/UA59341C2/uk unknown
- 1996-06-20 BR BR9610766A patent/BR9610766A/pt not_active Application Discontinuation
- 1996-06-20 CZ CZ0039098A patent/CZ296236B6/cs not_active IP Right Cessation
- 1996-06-20 AU AU59084/96A patent/AU710984B2/en not_active Ceased
- 1996-06-20 KR KR1019980700989A patent/KR100291882B1/ko not_active Expired - Fee Related
- 1996-06-20 SK SK166-98A patent/SK284209B6/sk unknown
- 1996-06-20 CN CNA031584969A patent/CN1615861A/zh active Pending
- 1996-06-20 US US09/011,426 patent/US6008233A/en not_active Expired - Fee Related
- 1996-06-20 WO PCT/IB1996/000592 patent/WO1997007098A1/en not_active Ceased
- 1996-06-20 TR TR1998/00208T patent/TR199800208T1/xx unknown
- 1996-06-20 JP JP09509083A patent/JP3099072B2/ja not_active Expired - Fee Related
- 1996-06-20 HU HU9802862A patent/HUP9802862A3/hu unknown
- 1996-06-20 ES ES96916266T patent/ES2170857T3/es not_active Expired - Lifetime
- 1996-06-20 RO RO98-00231A patent/RO120134B1/ro unknown
- 1996-06-20 PL PL96325050A patent/PL185603B1/pl not_active IP Right Cessation
- 1996-06-20 DK DK96916266T patent/DK0843661T3/da active
- 1996-06-20 PT PT96916266T patent/PT843661E/pt unknown
- 1996-06-20 DE DE69620191T patent/DE69620191T2/de not_active Expired - Fee Related
- 1996-06-20 IL IL12264996A patent/IL122649A/xx not_active IP Right Cessation
- 1996-06-20 AT AT96916266T patent/ATE215072T1/de not_active IP Right Cessation
- 1996-06-20 CN CN96195649A patent/CN1198739A/zh active Pending
- 1996-06-20 NZ NZ309134A patent/NZ309134A/en unknown
- 1996-06-20 RU RU98102116A patent/RU2140910C1/ru not_active IP Right Cessation
- 1996-06-20 CA CA002228752A patent/CA2228752C/en not_active Expired - Fee Related
- 1996-06-24 TW TW085107571A patent/TW495502B/zh not_active IP Right Cessation
- 1996-07-04 GT GT199600051A patent/GT199600051A/es unknown
- 1996-07-23 SA SA96170171A patent/SA96170171B1/ar unknown
- 1996-08-06 PE PE1996000587A patent/PE4898A1/es not_active Application Discontinuation
- 1996-08-07 DZ DZ960127A patent/DZ2083A1/fr active
- 1996-08-07 MA MA24335A patent/MA23957A1/fr unknown
- 1996-08-07 TN TNTNSN96104A patent/TNSN96104A1/fr unknown
- 1996-08-07 AR ARP960103904A patent/AR004676A1/es unknown
- 1996-08-08 AP APAP/P/1996/000856A patent/AP755A/en active
- 1996-08-08 ZA ZA9606760A patent/ZA966760B/xx unknown
- 1996-08-09 HR HR960372A patent/HRP960372B1/xx not_active IP Right Cessation
- 1996-08-09 RS YU46196A patent/RS49521B/sr unknown
- 1996-08-09 CO CO96042164A patent/CO4750830A1/es unknown
1997
- 1997-12-30 IS IS4643A patent/IS1945B/is unknown
1998
- 1998-02-10 OA OA9800021A patent/OA10664A/en unknown
- 1998-02-10 NO NO19980574A patent/NO310458B1/no unknown
- 1998-02-27 BG BG102289A patent/BG63678B1/bg unknown

Also Published As

Publication number	Publication date
AU5908496A (en)	1997-03-12
CZ296236B6 (cs)	2006-02-15
KR100291882B1 (ko)	2001-10-26
TNSN96104A1 (fr)	2005-03-15
IL122649A0 (en)	1998-08-16
NO980574D0 (no)	1998-02-10
DK0843661T3 (da)	2002-07-22
CN1615861A (zh)	2005-05-18
BG102289A (en)	1998-09-30
NZ309134A (en)	1999-09-29
NO980574L (no)	1998-02-10
PL325050A1 (en)	1998-07-06
SK16698A3 (en)	1999-06-11
HRP960372A2 (en)	1998-04-30
WO1997007098A1 (en)	1997-02-27
IS4643A (is)	1997-12-30
PL185603B1 (pl)	2003-06-30
ATE215072T1 (de)	2002-04-15
CN1198739A (zh)	1998-11-11
TW495502B (en)	2002-07-21
IL122649A (en)	2001-08-26
YU46196A (sh)	1999-07-28
RS49521B (sr)	2006-10-27
KR19990036321A (ko)	1999-05-25
RO120134B1 (ro)	2005-09-30
EP0843661B1 (en)	2002-03-27
DE69620191D1 (de)	2002-05-02
EP0843661A1 (en)	1998-05-27
HUP9802862A2 (hu)	1999-04-28
DE69620191T2 (de)	2002-07-18
CA2228752A1 (en)	1997-02-27
SA96170171B1 (ar)	2006-05-20
JPH10510552A (ja)	1998-10-13
CO4750830A1 (es)	1999-03-31
CZ39098A3 (cs)	1999-02-17
PE4898A1 (es)	1998-03-16
DZ2083A1 (fr)	2002-10-23
AP755A (en)	1999-08-02
RU2140910C1 (ru)	1999-11-10
CA2228752C (en)	2002-12-10
BR9610766A (pt)	1999-07-13
HUP9802862A3 (en)	1999-05-28
AR004676A1 (es)	1999-03-10
TR199800208T1 (is)	1998-05-21
NO310458B1 (no)	2001-07-09
ES2170857T3 (es)	2002-08-16
AU710984B2 (en)	1999-10-07
HRP960372B1 (en)	2003-04-30
UA59341C2 (uk)	2003-09-15
MX9801149A (es)	1998-05-31
US6008233A (en)	1999-12-28
BG63678B1 (bg)	2002-09-30
OA10664A (en)	2000-11-06
ZA966760B (en)	1998-02-09
GT199600051A (es)	1997-12-26
PT843661E (pt)	2002-07-31
SK284209B6 (en)	2004-11-03
MA23957A1 (fr)	1997-04-01
JP3099072B2 (ja)	2000-10-16
AP9600856A0 (en)	1996-10-31

Publication	Publication Date	Title
ATE215072T1 (de)	2002-04-15	(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4- phenylpiperidin-1-yl)-1-propanol-methansulfonat trihydrat
ATE189812T1 (de)	2000-03-15	1-alpha, 26-dihydroxy-d-homo-vitamin d3
IT1274840B (it)	1997-07-25	Apparecchiatura per trattamenti di dialisi.
ITMI951742A0 (it)	1995-08-04	Macchina per la costruzione di binari
ITTO930757A1 (it)	1995-04-15	Macchina per dialisi extracorporea.
FI960616A0 (fi)	1996-02-09	1-(2-(substituoitu-vinyyli))-3,4-dihydro-5H-2,3-bentsodiatsepiinijohdannaiset
MX213693B (es)	2003-04-11	Polimero cationico.
IT1301910B1 (it)	2000-07-07	Macchina per termoformatura.
IT1297636B1 (it)	1999-12-20	Macchina per la lavorazione di legno.
ITBO970653A0 (it)	1997-10-31	Macchina bordatrice.
FR2720390B1 (fr)	1997-12-05	Machine sectionnelle.
SI0843661T1 (en)	2002-06-30	(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
IT1269022B (it)	1997-03-18	Tappo per operazioni di sfecciatura.
IT1284729B1 (it)	1998-05-21	Apparecchiatura per trattamenti di dialisi.
IT235626Y1 (it)	2000-07-12	Macchina per i trattamenti di biotermolisi.
IT1274839B (it)	1997-07-25	Apparecchiatura perfezionata per trattamenti di dialisi.
IT234100Y1 (it)	2000-02-23	Macchina per vibromassaggi.
IT1284728B1 (it)	1998-05-21	Macchina per dialisi.
FI960615A0 (fi)	1996-02-09	1-(2-(substituoitu-vinyyli))-5H-2,3-bentsodiatsepiinijohdannaiset
ES1028775Y (es)	1995-08-16	Maquina de termorelieve.
ES1028132Y (es)	1995-05-01	Maquina desbrozadora.
IT243099Y1 (it)	2002-02-28	Struttura di morsetto,particolarmente per macchine avvolgitrici
ITMI941593A0 (it)	1994-07-26	Tetraidropiridine 3,3-disostituite
IT1268959B1 (it)	1997-03-18	Dispositivo di spazzolatura particolarmente per gelosie, persiane osimili.
ES1027687Y (es)	1995-03-01	Maquina paletizadora-despaletizadora.